Feed / BSX

Boston Scientific Corporation

BSX

Healthcare · 42.95 -4.5% today

Isolated · not yet confirmedMarket checked 11 Sept, 15:10 GMT-4

Market read

Boston Scientific Corporation's current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 26 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 14 directly disclosed connections are confirming.

Company-4.5% todayVolume comparison unavailable
Market group0 of 26 activeHigh-Beta Growth · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • BSX's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if BSX's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Medical Devices

No new filing conclusion is available. 0 of 26 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 14 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • BSX's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations601
Usable filing statements137
Verified relationships9
Evidence supporting the case
  • Latest annual revenue changed +19.9% year over year.
  • Operating margin changed +2.5 percentage points in the latest annual period.
  • Foreign exchange has repeated favorable evidence across 4 filings.
Evidence challenging the case

No qualifying adverse evidence was identified; that is not proof there is no downside.

Questions before a position

No credible peer-relative valuation comparison is available yet.

Longer-term price context

Price as of Sep 10, 2026

43.10
6m-38.1%12m-60.1%24m-47.0%
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$11.9B+19.9%$0.69+1.2%
2022-12-31$12.7B+6.7%$0.45+0.4%
2023-12-31$14.2B+12.3%$1.07+1.7%
2024-12-31$16.7B+17.6%$1.25+1.5%
2025-12-31$20.1B+19.9%$1.94+0.6%

What management says matters

Persistent and emerging business drivers

Supply chain and availabilitypositive · 5 filings
In the current and prior periods, we did not recognize any gains or losses on the components included in the assessment of hedge effectiveness in earnings.
10-Q · Aug 3, 2026
Foreign exchangepositive · 4 filings
Organic net sales growth excludes the impact of foreign currency fluctuations and net sales attributable to certain acquisitions and divestitures for which there are less than a full period of comparable net sales.
10-Q · Aug 3, 2026
Credit and interest ratespositive · 2 filings
49 Table of Content s Interest Expense The following table provides a summary of our Interest expense and average borrowing rate: Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Interest expense (in millions) $ (87) $ (79)…
10-Q · Nov 3, 2025
Tariffs and trade policypositive · 2 filings
In the first nine months of 2025, the primary factors that impacted gross profit margin were inventory charges of approximately $90 million resulting from the global discontinuation of the ACURATE platform, increased levels of tariffs and other period expense…
10-Q · Nov 3, 2025

Valuation discipline

Descriptive valuation snapshot

Price/sales 3.2× · EV/sales 3.1×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

42.95-4.5% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:10 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for BSX. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for BSX. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind BSX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

PENPenumbra, Inc.investeeMay 1, 2026

37 Table of Contents Contractual Obligations and Commitments On January 15, 2026, we announced our entry into a definitive agreement to acquire 100 percent of Penumbra, Inc.

Depended on by

IRTCiRhythm Holdings, Inc.competitorApr 30, 2026

In providing our iRhythm Services, we compete with BioTelemetry, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 19 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

BSX is currently a Follower in the organic co-movement group High-Beta Growth. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.